“The 10/90 Gap – Only 10% of global healthcare resources
are spent on developing countries where 90% of preventable
One key reason behind the gap is misalignment of corporate and social goals.
Companies seek to maximize their profits from each drug they discover
and produce. On the other hand, society hopes to maximize the total health
By creating the right incentives, the HIF will spur drug innovations that directly serve the majority of population and make relevant drugs accessible in even the poorest countries.